
| Scurvy and its Prevention and Control in Major Emergencies (WHO - OMS, 1999, 70 p.) |
| Scurvy |
![]() |
|
The main criteria for diagnosing scurvy are:
· A history of dietary inadequacy of vitamin C.· Clinical manifestations characteristic of a scorbutic state (Tables 3 and 4).
· Biochemical indices, i.e. low levels of vitamin C in the blood (serum, white blood cells and whole blood) and a low urinary excretion rate.
The clinical picture of scurvy in children is quite different from that seen in adults, the impact on growing bones being one of its earliest and most prominent distinguishing features. In contrast to adult scurvy, haemorrhaging is less common among children during the early stages of the disease.
Biochemical evaluation of vitamin C status in humans is usually conducted through a determination of serum (plasma) ascorbic acid levels. Serum levels of ascorbic acid show a linear relationship with vitamin C intake. When deprived of vitamin C, a subject's concentration of plasma ascorbic acid decreases rapidly while, with a given intake of the vitamin, the plasma ascorbic acid concentration will plateau at a given level (Sauberlich et al., 1974). The maximum plasma ascorbic acid level appears to be about 1.4 mg/100 ml, at which point renal clearance of the vitamin rises abruptly. Although low plasma ascorbic acid levels do not necessarily indicate scurvy, clinical cases of scurvy always have low or no plasma ascorbic acid. However, continued low levels of plasma ascorbic acid of less than 0.1 mg/100 ml would probably eventually lead to scurvy (Hodges et al., 1971).
There is also a well-defined relationship between whole blood ascorbic acid values and the body reserves of the vitamin, with signs of scurvy appearing when the whole blood ascorbate level falls below 0.3 mg/100 ml (Hodges et al., 1969). Whole blood ascorbic acid levels are probably a less sensitive indicator of vitamin C nutriture than serum levels of the vitamin since the ascorbic acid levels in red blood cells never fall to the low levels encountered in serum or plasma (Sauberlich et al., 1974).
Table 3. Clinical manifestations of scurvy in adults
|
Body system |
Typical lesion |
|
Skin: |
· Diffuse petechial haemorrhages* · Hyperkeratotic follicular papules** on the calves and buttocks with spiral unerupted hairs |
|
Mouth: |
· Bleeding gums |
|
Eye: |
Intra-ocular haemorrhages |
|
Blood: |
Moderately severe anaemia |
|
Bones: |
· Irregular masses of calcified
cartilage in fibrous tissue |
* Small purplish red spots due to intradermal or submucous bleeding.
** Thickening of the corneal layer or small elevations of the skin.
Table 4. Clinical manifestations of scurvy in infants and young children
|
Most frequent symptoms Possible symptoms |
White blood cell ascorbic acid concentrations are more closely related to tissue stores of the vitamin than are serum levels. With vitamin C deprivation, white blood cell ascorbic acid levels fall more slowly than plasma ascorbic acid levels and are most pronounced in association with the onset of signs of scurvy (Sauberlich et al., 1974). However, because determination of ascorbic acid in white blood cells is technically difficult and requires relatively large blood samples, it is impractical for routine use in nutrition surveys.
Table 5 proposes cutoff points for mild, moderate and severe vitamin C deficiency based on ascorbic acid levels in whole blood, plasma and white blood cells. Table 6 suggests guidelines for differentiating among levels of risk for vitamin C deficiency in a population.
Table 5. Cutoff points for interpreting vitamin C biochemical data (all age groups)
| |
Deficient |
Low |
Acceptable |
|
Serum ascorbic acid (mg/100 ml) |
< 0.2 |
0.2 - 0.29 |
> 0.3 |
|
Leukocyte ascorbic acid* (nmol/108 cells) |
< 57 |
57 - 114 |
> 114 |
|
Whole blood ascorbic acid (mg/100 ml) |
< 0.3 |
0.3 - 0.49 |
> 0.5 |
Source: Sauberlich et al.,1974.
* Data kindly updated by H.E.Sauberlich (1999)
Table 6. Provisional criteria for severity of public health problem of vitamin C deficiency
| |
Severity of public health problem | ||
|
Indicator |
Mild |
Moderate |
Severe |
|
Clinical signs: |
³1 clinical case; <1% of population in age group concerned |
1-4% of population in age group concerned |
³5% of population in age group concerned |
|
Serum ascorbic acid |
| | |
|
<0.2 mg/100ml |
10-29 % |
30-49 % |
³50 % |
|
<0.3 mg/100ml |
30-49 % |
50-69 % |
³70 % |
Derived from: Sauberlich et al., 1974, Desenclos JC et al., 1989.